The reaction mechanism of human C5 in immune hemolysis - PubMed (original) (raw)
The reaction mechanism of human C5 in immune hemolysis
N R Cooper et al. J Exp Med. 1970.
Abstract
The data presented here indicate that the C5 reaction step may proceed via the specific attachment of C5 to EAC1,4,2,3 and the formation of a hemolytically active C5 intermediate complex. During this process only a minor proportion (less than 4%) of C5 offered to EAC1,4,2,3 becomes bound, although the remaining C5 also participates in the reaction as evidenced by its inactivation in the fluid phase. Once bound, C5 is exceptionally efficient in producing hemolysis, requiring less than seven specifically bound molecules per cell for the production of a hemolytic lesion. The extent of formation of the C5 intermediate complex is primarily dependent on the number of molecules of C4, 2 and C3 present on the cells employed for its generation. In these respects, the mode of action of C5 is completely analogous to that of the other components of complement thus far investigated. The C5 step differs, however, in other aspects. The binding of C5 is influenced by C6 and C7, components which are thought to act subsequent to it in the complement sequence. In addition, the hemolytic activity of the isolated C5 intermediate complex is exceedingly labile, having an average half-life at 30 degrees C of only 9 min. This characteristic distinguishes the C5 step, along with the C2 step, as potentially rate-limiting in the complement reaction. However, unlike C2, C5 remains firmly cell-bound during the decay process and apparently undergoes an alteration in situ which renders it hemolytically unreactive. Finally, C5 is unique in that it readily adsorbs in native form to unsensitized erythrocytes. This nonspecifically bound C5 remains firmly attached, although it may be specifically utilized as a source of C5 by an ongoing complement reaction. The significance of the marked affinity of native C5 for cell-surface receptors remains to be determined.
Similar articles
- Molecular analysis of the membrane attack mechanism of complement.
Kolb WP, Haxby JA, Arroyave CM, Müller-Eberhard HJ. Kolb WP, et al. J Exp Med. 1972 Mar 1;135(3):549-66. doi: 10.1084/jem.135.3.549. J Exp Med. 1972. PMID: 5058233 Free PMC article. - Independent and consecutive action of C5, C6 and C7 in immune hemolysis. II. Formation and decay of the intermediate complexes EAC1-5 and EAC1-6.
Hadding U, Bitter-Suermann D, Wellensiek HJ. Hadding U, et al. Immunochemistry. 1970 Dec;7(12):967-76. doi: 10.1016/0019-2791(70)90003-0. Immunochemistry. 1970. PMID: 5503628 No abstract available. - Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5.
Bitter-Suermann D, Hadding U, Melchert F, Wellensiek HJ. Bitter-Suermann D, et al. Immunochemistry. 1970 Dec;7(12):955-65. doi: 10.1016/0019-2791(70)90002-9. Immunochemistry. 1970. PMID: 5503627 No abstract available. - Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
Fearon DT, Daha MR, Strom TB, Weiler JM, Carpenter CB, Austen KF. Fearon DT, et al. Transplant Proc. 1977 Mar;9(1):729-39. Transplant Proc. 1977. PMID: 325806 Review. - Interactions of complement with the red-cell membrane.
Rosse WF. Rosse WF. Semin Hematol. 1979 Apr;16(2):128-39. Semin Hematol. 1979. PMID: 384519 Review.
Cited by
- Structural basis for membrane attack complex inhibition by CD59.
Couves EC, Gardner S, Voisin TB, Bickel JK, Stansfeld PJ, Tate EW, Bubeck D. Couves EC, et al. Nat Commun. 2023 Feb 16;14(1):890. doi: 10.1038/s41467-023-36441-z. Nat Commun. 2023. PMID: 36797260 Free PMC article. - Soluble MAC is primarily released from MAC-resistant bacteria that potently convert complement component C5.
Doorduijn DJ, Lukassen MV, van 't Wout MFL, Franc V, Ruyken M, Bardoel BW, Heck AJR, Rooijakkers SHM. Doorduijn DJ, et al. Elife. 2022 Aug 10;11:e77503. doi: 10.7554/eLife.77503. Elife. 2022. PMID: 35947526 Free PMC article. - Systems Biology Modeling of the Complement System Under Immune Susceptible Pathogens.
Zewde NT, Hsu RV, Morikis D, Palermo G. Zewde NT, et al. Front Phys. 2021 Apr 29;9:603704. doi: 10.3389/fphy.2021.603704. Front Phys. 2021. PMID: 35145963 Free PMC article. - How Structures of Complement Complexes Guide Therapeutic Design.
Bickel JK, Voisin TB, Tate EW, Bubeck D. Bickel JK, et al. Subcell Biochem. 2021;96:273-295. doi: 10.1007/978-3-030-58971-4_7. Subcell Biochem. 2021. PMID: 33252733 Review. - Bacterial killing by complement requires direct anchoring of membrane attack complex precursor C5b-7.
Doorduijn DJ, Bardoel BW, Heesterbeek DAC, Ruyken M, Benn G, Parsons ES, Hoogenboom BW, Rooijakkers SHM. Doorduijn DJ, et al. PLoS Pathog. 2020 Jun 22;16(6):e1008606. doi: 10.1371/journal.ppat.1008606. eCollection 2020 Jun. PLoS Pathog. 2020. PMID: 32569291 Free PMC article.
References
- J Exp Med. 1966 Jan 1;123(1):33-54 - PubMed
- Int Arch Allergy Appl Immunol. 1966;29(2):185-9 - PubMed
- J Immunol. 1966 Nov;97(5):680-5 - PubMed
- Immunochemistry. 1966 May;3(3):163-76 - PubMed
- J Immunol. 1967 Jan;98(1):119-31 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous